Oklahoma State University Center for Health Sciences
Tulsa, Oklahoma, 74127, United States
NCT Number: NCT00324402
To evaluate the maternal blood concentrations of brain natriuretic peptide (BNP) during the second and third trimesters of a normal pregnancy. We will attempt to define a normal range for pregnancy and any outliers that may serve as markers for abnormal cardiovascular physiology.
Looking for future studies?
Notify Me18 year–40 year
Female
Observational
Tulsa, Oklahoma, 74127, United States
The brain natriuretic peptide (BNP) is a useful marker for volume overload, increased filling pressures and stretching of the myocardium. The current literature contains limited and unreliable information regarding normal BNP values in pregnancy. After baseline echocardiogram to detect individuals with asymptomatic structural defects, the participants will submit to 3 blood draws during the second and third trimester and at delivery to determine normal pregnancy values.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Oklahoma State University Center for Health Sciences
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01085955
Cardiomyopathies, Cardiomyopathy
Los Angeles, California, United States
View Trial DetailsNCT03057561
Arterial Occlusive Diseases, Arteriosclerosis
View Trial DetailsNCT01143519
Cancer, Cardiomyopathies
Research Triangle Park, North Carolina, United States
View Trial DetailsNCT07272330
Cardiomyopathies, Cardiomyopathy
Beijing, Beijing Municipality, China
View Trial Details